Search Results

Return to List
Results 1–11 of 11
Sort By: Relevance | Date | Title
1.

Aromatase Inhibitors in Gynecologic Practice

Committee Opinion Number 663, June 2016

(Replaces Committee Opinion Number 412, August 2008)

ABSTRACT Aromatase inhibitors have been used for the treatment of breast cancer ovulation induction endometriosis and other estrogenmodulated conditions For women with breast cancer bone mineral density screening is recommended with longterm aromatase inhibitor use because of risk of osteoporosis ...

June 2016

PDF Format
2.

Gynecologic Concerns in Children and Adolescents With Cancer

Committee Opinion Number 607, August 2014

ABSTRACT Advancements in radiation therapy chemotherapy surgery and multimodal treatment have dramatically improved childhood cancer survival However cancer and its treatment may have immediate or delayed adverse effects on reproductive health Gynecologists should be prepared to manage gynecologic...

August 2014

PDF Format
3.

Hereditary Cancer Syndromes and Risk Assessment

Committee Opinion Number 634, June 2015

ABSTRACT A hereditary cancer syndrome is a genetic predisposition to certain types of cancer often with onset at an early age caused by inherited mutations in one or more genes Cases of cancer commonly encountered by obstetriciangynecologists or other obstetricgynecologic providersmdashsuch as bre...

June 2015

PDF Format
4.

Human Papillomavirus Vaccination

Committee Opinion Number 641, September 2015

(This Committee Opinion Replaces Committee Opinion Number 588)

ABSTRACT Human papillomavirus HPV is associated with the development of anogenital cancer including cervical vaginal vulvar penile and anal oropharyngeal cancer and genital warts Human papillomavirus vaccination can significantly reduce the incidence of anogenital cancer and genital warts Despite ...

September 2015

PDF Format
5.

Management of Vulvar Intraepithelial Neoplasia

Committee Opinion Number 675, October 2016

(Replaces Committee Opinion Number 509, November 2011)

ABSTRACT Vulvar intraepithelial neoplasia VIN is an increasingly common problem particularly among women in their 40s Although spontaneous regression has been reported VIN should be considered a premalignant condition Immunization with the quadrivalent or 9valent human papillomavirus vaccine which...

October 2016

PDF Format
6.

Oocyte Cryopreservation

Committee Opinion Number 584, January 2014

(Reaffirmed 2016)

ABSTRACT In 2013 the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology published a joint document Mature Oocyte Cryopreservation A Guideline which addresses advances in techniques to freeze human eggs that have resulted in significant recent improvemen...

January 2014

PDF Format
7.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Committee Opinion Number 606, August 2014

(Reaffirmed 2016)

ABSTRACT Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding emerg...

August 2014

PDF Format
8.

Salpingectomy for Ovarian Cancer Prevention

Committee Opinion Number 620, January 2015

ABSTRACT Ovarian cancer has the highest mortality rate out of all types of gynecologic cancer and is the fifth leading cause of cancer deaths among women Current attempts at screening for ovarian cancer have been unsuccessful and are associated with falsepositive test results that lead to unnecess...

January 2015

PDF Format
9.

Tamoxifen and Uterine Cancer

Committee Opinion Number 601, June 2014

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT Tamoxifen a nonsteroidal antiestrogen agent is widely used as adjunctive therapy for women with breast cancer and it has been approved by the US Food and Drug Administration for adjuvant treatment of breast cancer treatment of metastatic breast cancer and reduction in breast cancer incide...

June 2014

PDF Format
10.

The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer

Committee Opinion Number 477, March 2011

(Replaces No. 280, December 2002)

ABSTRACT Epithelial ovarian cancer is most commonly detected in an advanced stage when the overall 5year survival rate is 2030 Detection of earlystage ovarian cancer results in improved survival Currently there is no effective strategy for ovarian cancer screening Women with persistent and progres...

March 2011

PDF Format
11.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Committee Opinion Number 659, March 2016

ABSTRACT Cancer treatment should address femalespecific survivorship issues including the hypoestrogenicrelated adverse effects of cancer therapies or of natural menopause in survivors Systemic and vaginal estrogen are widely used for symptomatic relief of vasomotor symptoms sexual dysfunction and...

March 2016

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998